Clinical Trial Detail

NCT ID NCT02576444
Title OLAParib COmbinations (OLAPCO)
Recruitment Active, not recruiting
Gender both
Phase Phase II
Variant Requirements Yes
Sponsors Joseph Paul Eder
Indications

Advanced Solid Tumor

Therapies

Adavosertib + Olaparib

Olaparib

Capivasertib + Olaparib

AZD6738 + Olaparib

Age Groups: adult senior

Additional content available in CKB BOOST